FATE
FATE THERAPEUTICS INC
FATE THERAPEUTICS INC (FATE) has 6 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: May 21, 2026.
Insiders have net sold $103K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Bahram Valamehr
- Employees:181
- HQ:San Diego, CA, US
- IPO:2013-10-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$103K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$293.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
TAHL CINDYFirst filing | See Remarks | Sale | 25,590 | $48K | May 21 | SEC ↗ |
Valamehr BahramFirst filing | President and CEO | Sale | 28,946 | $54K | May 21 | SEC ↗ |
Related companies
FATE THERAPEUTICS INC is in the Healthcare sector.